Therapy: Azithromycin and decolonization after HUS

Nature Reviews Nephrology

Volumn 8, Issue 6, 2012, Pages 317-318

  Seifert, Michael E ^a   Tarr, Phillip I ^b  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN;

BACTERIAL COLONIZATION; MICROBIOLOGICAL PARAMETERS; NONHUMAN; OBSERVATIONAL STUDY; PRIORITY JOURNAL; REVIEW; SHIGA TOXIN PRODUCING ESCHERICHIA COLI;

ANTI-BACTERIAL AGENTS; AZITHROMYCIN; ESCHERICHIA COLI INFECTIONS; HEMOLYTIC-UREMIC SYNDROME; HUMANS; SHIGA-TOXIGENIC ESCHERICHIA COLI;

EID: 84861725772     PISSN: 17595061     EISSN: 1759507X     Source Type: Journal    
DOI: 10.1038/nrneph.2012.87     Document Type: Review

References (10)

1. Nitschke, M. et al. Association between azithromycin therapy and duration of bacterial shedding among patients with Shiga toxin-producing enteroaggregative Escherichia coli O104:H4. JAMA 307, 1046-1052 (2012).
2. Nielsen, S. et al. Desperately seeking diarrhoea: outbreak of haemolytic uraemic syndrome caused by emerging sorbitol-fermenting shiga toxin-producing Escherichia coli O157:H-, Germany, 2009. Zoonoses Public Health 58, 567-572 (2011).
3. Belongia, E. A. et al. Transmission of Escherichia coli O157:H7 infection in Minnesota child day-care facilities. JAMA 269, 883-888 (1993).
4. Smith, K. E. et al. Antibiotic treatment of Escherichia coli O157 infection and the risk of hemolytic uremic syndrome, Minnesota. Pediatr. Infect. Dis. J. 31, 37-41 (2012).
5. Safdar, N., Said, A., Gangnon, R. E. & Maki, D. G. Risk of hemolytic uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 enteritis: a meta-analysis. JAMA 288, 996-1001 (2002).
6. Wong, C. S. et al. Risk factors for the hemolytic uremic syndrome in children infected with Escherichia coli O157:H7: a multivariable analysis. Clin. Infect. Dis. http://dx.doi.org/10.1093/cid/cis299.
7. Werber, D., Mason, B. W., Evans, M. R. & Salmon, R. L. Preventing household transmission of Shiga toxin-producing Escherichia coli O157 infection: promptly separating siblings might be the key. Clin. Infect. Dis. 46, 1189-1196 (2008).
8. Hickey, C. A. et al. Early volume expansion during diarrhea and relative nephroprotection during subsequent hemolytic uremic syndrome. Arch. Pediatr. Adolesc. Med. 165, 884-889 (2011).
9. Ake, J. A. et al. Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion. Pediatrics 115, e673-e680 (2005).
10. Bielaszewska, M. et al. Epidemic Escherichia coli O104:H4: effects of antibiotics on Shiga toxin 2 production and bacteriophage induction. Antimicrob. Agents Chemother. http://dx.doi.org/10.1128/AAC.06315-11. 320-321